000 -LEADER |
fixed length control field |
00676nam a22001937a 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20191102114217.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
191102t2018 flu||||| |||| 00| 0 eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9781138775503 |
041 ## - Language |
Language code of text/sound track or separate title |
eng |
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Edition number |
23 |
Classification number |
338.476151 |
Item number |
N577 |
100 1# - MAIN ENTRY--PERSONAL NAME |
9 (RLIN) |
35510 |
Personal name |
Niazi, Sarfaraz, |
Dates associated with a name |
1949- |
245 10 - IMMEDIATE SOURCE OF ACQUISITION NOTE |
Title |
Biosimilars and interchangeable biologics : |
Remainder of title |
strategic elements / |
Statement of responsibility, etc |
Sarfaraz K. Niazi. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
Place of publication, distribution, etc |
Boca Raton, FL : |
Name of publisher, distributor, etc |
CRC Press, |
Date of publication, distribution, etc |
2018. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
xlv, 599 p. : |
Other physical details |
co. ill ; |
Dimensions |
29 cm |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
9 (RLIN) |
4192 |
Topical term or geographic name as entry element |
Pharmaceutical biotechnology. |
|
9 (RLIN) |
236 |
Topical term or geographic name as entry element |
Biopharmaceutics |
General subdivision |
methods. |
|
Topical term or geographic name as entry element |
Pharmaceutical industry |
General subdivision |
Technological innovations. |
9 (RLIN) |
44471 |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
|
Item type |
Book |